Trial Profile
A phase I trial to investigate CAM-2058
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2017
Price :
$35
*
At a glance
- Drugs Buprenorphine/granisetron (Primary)
- Indications Nausea and vomiting; Pain
- Focus Adverse reactions
- 03 Nov 2017 New trial record